Rhabdomyolysis after ezetimibe/simvastatin therapy in an HIV-infected patient

NDT Plus

Volumn 1, Issue 3, 2008, Pages 157-161

  Chanson, Noemie ^a   Bossi, Philippe ^a   Schneider, Luminita ^a   Bourry, Edward ^a   Izzedine, Hassane ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Drug drug interaction; HIV infection; Rhabdomyolysis; Statin

Indexed keywords

ABACAVIR; ACETYLSALICYLIC ACID; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BISOPROLOL; CREATININE; EZETIMIBE; INDINAVIR; LAMIVUDINE; PERINDOPRIL; PRAVASTATIN; RITONAVIR; SIMVASTATIN; TROPONIN I;

ABNORMAL URINE COMPOSITION; ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD CHEMISTRY; CASE REPORT; CREATININE BLOOD LEVEL; DRUG EFFICACY; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLIPIDEMIA; MALE; MIXED INFECTION; MUSCLE WEAKNESS; MYALGIA; MYOGLOBINURIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHABDOMYOLYSIS; TREATMENT DURATION; TREATMENT RESPONSE; URINALYSIS;

EID: 44449164424     PISSN: 17530784     EISSN: 17530792     Source Type: Journal    
DOI: 10.1093/ndtplus/sfn012     Document Type: Article

References (19)

1. Bennett MT, Johns KW, Bondy GP. Ezetimibe is effective when added to maximally tolerated lipid lowering therapy in patients with HIV. Lipids Health Dis 2007; 6: 15
2. Food and Drug Administration. Drugs@FDA. Available at http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm (accessed 30 August 2007)
3. Weffald LA, Flach LA. Myopathy associated with atorvastatin-ezetimibe combination therapy. Pharmacotherapy 2007; 27: 309-311
4. Aboulafia DM, Johnston R. Simvastatin-induced rhabdomyolysis in an HIV-infected patient with coronary artery disease. AIDS Patient Care STDS 2000; 14: 13-18
5. Mastroianni CM, d' Ettorre G, Forcina G et al. Rhabdomyolysis after cerivastatin-gemfibrozil therapy in an HIV-infected patient with protease inhibitor-related hyperlipidemia. AIDS 2001; 15: 820-821
6. Cheng CH, Miller C, Lowe C et al. Rhabdomyolysis due to probable interaction between simvastatin and ritonavir. Am J Health Syst Pharm 2002; 59: 728-730
7. Castro JG, Gutierrez L. Rhabdomyolysis with acute renal failure probably related to the interaction of atorvastatin and delavirdine. Am J Med 2002; 112: 505
8. Hare CB, Vu MP, Grunfeld C et al. Simvastatin-nelfinavir interaction implicated in rhabdomyolysis and death. Clin Infect Dis 2002; 35: E111-e112
9. Mah Ming JB, Gill MJ. Drug-induced rhabdomyolysis after concomitant use of clarithromycin, atorvastatin, and lopinavir/ritonavir in a patient with HIV. AIDS Patient Care STDS 2003; 17: 207-210
10. Moro H, Tsukada H, Tanuma A et al. Rhabdomyolysis after simvastatin therapy in an HIV-infected patient with chronic renal failure. AIDS Patient Care STDS 2004; 18: 687-690
11. Schmidt GA, Hoehns JD, Purcell JL et al. Severe rhabdomyolysis and acute renal failure secondary to concomitant use of simvastatin, amiodarone, and atazanavir. J Am Board Fam Med 2007; 20: 411-416
12. McKenney JM, Jones PH, Bays HE et al. Comparative effects on lipid levels of combination therapy with a statin and extended-release niacin or ezetimibe versus a statin alone (the COMPELL study). Atherosclerosis 2007; 192: 432-437
13. Coll B, Aragones G, Parra S et al. Ezetimibe, effectively decreases LDL-cholesterol in HIV-infected patients. AIDS 2006; 20: 1675-1677
14. Negredo E, Molto J, Puig J et al. Ezetimibe, a promising lipid lowering agent for the treatment of dyslipidaemia in HIV-infected patients with poor response to statins. AIDS 2006; 20: 2159-2164
15. Simard C, Poitier P. Ezetimibe-associated myopathy in monotherapy and in combination therapy with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. Can J Cardiol 2006; 22: 141-144
16. Fichtenbaum CJ, Gerber JG, Rosenkranz SL et al., NIAID AIDS Clinical Trials Group. Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG study A5047. AIDS 2002; 16:569-577
17. Penzak SR, Chuck SK, Stajich GV. Safety and efficacy of HMG-CoA reductase inhibitors for treatment of hyperlipidemia in patients with HIV infection. Pharmacotherapy 2000; 20: 1066-1071
18. Benesic A, Zilly M, Kluge F et al. Lipid lowering therapy with fluvastatin and pravastatin in patients with HIV infection and antiretroviral therapy: Comparison of efficacy and interaction with indinavir. Infection 2004; 32: 229-233
19. Schech S, Graham D, Staffa J et al. Risk factors for statin-associated rhabdomyolysis. Pharmacoepidemiol Drug Saf 2007; 16: 352-358